Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.74
-0.08-2.09%
At close: -
$3.74
0.000.00%
After Hours: May 23, 5:13 PM EDT
Comments
Loading...
GoodRx Holdings Analyst Ratings and Price Targets | NASDAQ:GDRX | Benzinga
GoodRx Holdings Inc has a consensus price target of $8.02 based on the ratings of 27 analysts. The high is $16 issued by TD Cowen on May 16, 2024. The low is $4.5 issued by B of A Securities on January 2, 2024. The 3 most-recent analyst ratings were released by UBS, Goldman Sachs, and Wells Fargo on May 13, 2025, May 9, 2025, and April 29, 2025, respectively. With an average price target of $5.75 between UBS, Goldman Sachs, and Wells Fargo, there's an implied 53.74% upside for GoodRx Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Goldman Sachs
Wells Fargo
Truist Securities
Citigroup
1calculated from analyst ratings
Analyst Ratings for GoodRx Holdings
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2025 | Buy Now | 40.37% | UBS | Kevin Caliendo71% | $6 → $5.25 | Maintains | Neutral | Get Alert |
| 05/09/2025 | Buy Now | 33.69% | Goldman Sachs | Eric Sheridan79% | $6 → $5 | Maintains | Neutral | Get Alert |
| 04/29/2025 | Buy Now | 87.17% | Wells Fargo | Stan Berenshteyn40% | $8 → $7 | Maintains | Overweight | Get Alert |
| 04/10/2025 | Buy Now | 47.06% | Truist Securities | Jailendra Singh36% | $6.5 → $5.5 | Maintains | Hold | Get Alert |
| 02/28/2025 | Buy Now | 113.9% | Wells Fargo | Stan Berenshteyn40% | $9 → $8 | Maintains | Overweight | Get Alert |
| 01/10/2025 | Buy Now | 67.11% | Citigroup | Daniel Grosslight39% | $7 → $6.25 | Maintains | Buy | Get Alert |
| 01/08/2025 | Buy Now | 60.43% | Keybanc | Scott Schoenhaus45% | $7 → $6 | Maintains | Overweight | Get Alert |
| 12/17/2024 | Buy Now | 60.43% | Morgan Stanley | Craig Hettenbach59% | $7 → $6 | Maintains | Equal-Weight | Get Alert |
| 11/13/2024 | Buy Now | 87.17% | Citigroup | Daniel Grosslight39% | $10 → $7 | Maintains | Buy | Get Alert |
| 11/11/2024 | Buy Now | 60.43% | Barclays | Stephanie Davis41% | $10 → $6 | Maintains | Overweight | Get Alert |
| 08/16/2024 | Buy Now | 167.38% | RBC Capital | Sean Dodge46% | $10 → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2024 | Buy Now | 127.27% | UBS | Kevin Caliendo71% | $9 → $8.5 | Maintains | Neutral | Get Alert |
| 08/09/2024 | Buy Now | 167.38% | Citigroup | Daniel Grosslight39% | $11 → $10 | Maintains | Buy | Get Alert |
| 06/10/2024 | Buy Now | 154.01% | Morgan Stanley | Craig Hettenbach59% | $7 → $9.5 | Maintains | Equal-Weight | Get Alert |
| 05/23/2024 | Buy Now | 167.38% | RBC Capital | Mark Mahaney82% | $8 → $10 | Upgrade | Sector Perform → Outperform | Get Alert |
| 05/20/2024 | Buy Now | 167.38% | Barclays | Stephanie Davis41% | $9 → $10 | Maintains | Overweight | Get Alert |
| 05/16/2024 | Buy Now | 167.38% | Raymond James | John Ransom76% | → $10 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/16/2024 | Buy Now | 327.81% | TD Cowen | Charles Rhyee36% | $14 → $16 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 140.64% | Keybanc | Scott Schoenhaus45% | → $9 | Upgrade | Sector Weight → Overweight | Get Alert |
| 03/25/2024 | Buy Now | 167.38% | Wells Fargo | Stan Berenshteyn40% | → $10 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/08/2024 | Buy Now | 113.9% | RBC Capital | Sean Dodge46% | $8 → $8 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 03/01/2024 | Buy Now | 113.9% | UBS | Kevin Caliendo71% | $5 → $8 | Maintains | Neutral | Get Alert |
| 03/01/2024 | Buy Now | 100.53% | Wells Fargo | Stan Berenshteyn40% | $6 → $7.5 | Maintains | Equal-Weight | Get Alert |
| 03/01/2024 | Buy Now | 113.9% | RBC Capital | Sean Dodge46% | $7 → $8 | Maintains | Sector Perform | Get Alert |
| 03/01/2024 | Buy Now | 100.53% | Goldman Sachs | Eric Sheridan79% | $6.5 → $7.5 | Maintains | Neutral | Get Alert |
| 03/01/2024 | Buy Now | 113.9% | Truist Securities | Jailendra Singh36% | $7.5 → $8 | Maintains | Hold | Get Alert |
| 03/01/2024 | Buy Now | 274.33% | TD Cowen | Charles Rhyee36% | $12 → $14 | Maintains | Outperform | Get Alert |
| 03/01/2024 | Buy Now | 167.38% | JP Morgan | Lisa Gill56% | $7 → $10 | Upgrade | Neutral → Overweight | Get Alert |
| 03/01/2024 | Buy Now | 140.64% | Barclays | Steve Valiquette53% | $8 → $9 | Maintains | Overweight | Get Alert |
| 02/26/2024 | Buy Now | 113.9% | Leerink Partners | Michael Cherny78% | → $8 | Initiates | → Outperform | Get Alert |
| 01/16/2024 | Buy Now | 87.17% | RBC Capital | Sean Dodge46% | $5 → $7 | Maintains | Sector Perform | Get Alert |
| 01/12/2024 | Buy Now | 100.53% | Truist Securities | Jailendra Singh36% | $5.5 → $7.5 | Maintains | Hold | Get Alert |
| 01/02/2024 | Buy Now | 20.32% | B of A Securities | Michael Cherny78% | $8 → $4.5 | Downgrade | Buy → Underperform | Get Alert |
| 11/17/2023 | Buy Now | 60.43% | JP Morgan | Doug Anmuth86% | $7 → $6 | Maintains | Neutral | Get Alert |
| 11/13/2023 | Buy Now | 60.43% | Goldman Sachs | Eric Sheridan79% | $7 → $6 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | 33.69% | RBC Capital | Sean Dodge46% | $8 → $5 | Maintains | Sector Perform | Get Alert |
| 11/10/2023 | Buy Now | 60.43% | Goldman Sachs | Eric Sheridan79% | $7 → $6 | Maintains | Neutral | Get Alert |
| 11/10/2023 | Buy Now | 47.06% | Truist Securities | Jailendra Singh36% | $8 → $5.5 | Maintains | Hold | Get Alert |
| 11/10/2023 | Buy Now | 47.06% | Morgan Stanley | Ricky Goldwasser79% | $8 → $5.5 | Maintains | Equal-Weight | Get Alert |
| 09/14/2023 | Buy Now | 87.17% | JP Morgan | Doug Anmuth86% | $6 → $7 | Maintains | Neutral | Get Alert |
| 08/11/2023 | Buy Now | 87.17% | Goldman Sachs | Eric Sheridan79% | $6.25 → $7 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 113.9% | Deutsche Bank | George Hill61% | $6 → $8 | Maintains | Hold | Get Alert |
| 08/10/2023 | Buy Now | 167.38% | Guggenheim | Sandy Draper73% | $8 → $10 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 60.43% | JP Morgan | Doug Anmuth86% | $5 → $6 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 194.12% | Citigroup | Daniel Grosslight39% | $7 → $11 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 167.38% | Evercore ISI Group | Mark Mahaney82% | $7 → $10 | Maintains | In-Line | Get Alert |
| 08/10/2023 | Buy Now | 87.17% | Goldman Sachs | Eric Sheridan79% | $6.25 → $7 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 113.9% | Credit Suisse | Jonathan Yong65% | $7 → $8 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 113.9% | RBC Capital | Sean Dodge46% | $6 → $8 | Maintains | Sector Perform | Get Alert |
| 08/10/2023 | Buy Now | 154.01% | DA Davidson | Robert Simmons54% | → $9.5 | Upgrade | Neutral → Buy | Get Alert |
| 08/10/2023 | Buy Now | 87.17% | Wells Fargo | Stan Berenshteyn40% | $6 → $7 | Maintains | Equal-Weight | Get Alert |
| 07/31/2023 | Buy Now | 220.86% | TD Cowen | Charles Rhyee36% | $6.5 → $12 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/18/2023 | Buy Now | 87.17% | Truist Securities | Jailendra Singh36% | $6 → $7 | Maintains | Hold | Get Alert |
| 07/17/2023 | Buy Now | 113.9% | Morgan Stanley | Ricky Goldwasser79% | $6 → $8 | Maintains | Equal-Weight | Get Alert |
| 07/12/2023 | Buy Now | — | Keybanc | Scott Schoenhaus45% | — | Maintains | Sector Weight | Get Alert |
| 05/11/2023 | Buy Now | 113.9% | B of A Securities | Michael Cherny78% | $9 → $8 | Maintains | Buy | Get Alert |
| 05/11/2023 | Buy Now | 60.43% | RBC Capital | Sean Dodge46% | → $6 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/11/2023 | Buy Now | 67.11% | Goldman Sachs | Eric Sheridan79% | $7 → $6.25 | Maintains | Neutral | Get Alert |
| 05/11/2023 | Buy Now | 87.17% | Citigroup | Daniel Grosslight39% | $7.5 → $7 | Maintains | Buy | Get Alert |
| 03/08/2023 | Buy Now | 100.53% | Citigroup | Daniel Grosslight39% | $7 → $7.5 | Maintains | Buy | Get Alert |
| 03/07/2023 | Buy Now | 113.9% | Deutsche Bank | George Hill61% | $7 → $8 | Maintains | Hold | Get Alert |
| 03/02/2023 | Buy Now | 87.17% | Goldman Sachs | Eric Sheridan79% | $8 → $7 | Maintains | Neutral | Get Alert |
| 03/02/2023 | Buy Now | 113.9% | Credit Suisse | Jonathan Yong65% | $9 → $8 | Maintains | Neutral | Get Alert |
| 03/02/2023 | Buy Now | 60.43% | Wells Fargo | Stan Berenshteyn40% | $5.5 → $6 | Maintains | Equal-Weight | Get Alert |
| 03/01/2023 | Buy Now | 87.17% | Goldman Sachs | Eric Sheridan79% | $8 → $7 | Maintains | Neutral | Get Alert |
| 01/18/2023 | Buy Now | 113.9% | Barclays | Steve Valiquette53% | $9 → $8 | Maintains | Overweight | Get Alert |
| 12/01/2022 | Buy Now | 87.17% | Citigroup | Daniel Grosslight39% | → $7 | Initiates | → Buy | Get Alert |
| 11/09/2022 | Buy Now | 113.9% | Goldman Sachs | Eric Sheridan79% | $10 → $8 | Maintains | Neutral | Get Alert |
| 11/09/2022 | Buy Now | 60.43% | RBC Capital | Sean Dodge46% | $11 → $6 | Maintains | Sector Perform | Get Alert |
| 11/09/2022 | Buy Now | 60.43% | Morgan Stanley | Ricky Goldwasser79% | $10 → $6 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | 113.9% | JP Morgan | Doug Anmuth86% | $10 → $8 | Upgrade | Underweight → Neutral | Get Alert |
| 10/11/2022 | Buy Now | 140.64% | Barclays | Ross Sandler70% | $13 → $9 | Maintains | Overweight | Get Alert |
| 09/16/2022 | Buy Now | — | Keybanc | Scott Schoenhaus45% | — | Initiates | → Sector Weight | Get Alert |
| 09/07/2022 | Buy Now | 73.8% | Truist Securities | Jailendra Singh36% | → $6.5 | Initiates | → Hold | Get Alert |
| 08/12/2022 | Buy Now | 113.9% | DA Davidson | Robert Simmons54% | → $8 | Initiates | → Neutral | Get Alert |
| 08/10/2022 | Buy Now | 167.38% | Morgan Stanley | Ricky Goldwasser79% | $10.5 → $10 | Maintains | Equal-Weight | Get Alert |
| 08/09/2022 | Buy Now | 194.12% | Credit Suisse | Jonathan Yong65% | $10 → $11 | Maintains | Neutral | Get Alert |
| 08/09/2022 | Buy Now | 167.38% | Goldman Sachs | Eric Sheridan79% | $9 → $10 | Maintains | Neutral | Get Alert |
| 08/09/2022 | Buy Now | 194.12% | RBC Capital | Sean Dodge46% | $6.5 → $11 | Maintains | Sector Perform | Get Alert |
| 08/09/2022 | Buy Now | 247.59% | Barclays | Steve Valiquette53% | $12 → $13 | Maintains | Overweight | Get Alert |
| 08/09/2022 | Buy Now | 194.12% | SVB Leerink | Stephanie Davis41% | $8 → $11 | Maintains | Market Perform | Get Alert |
| 07/20/2022 | Buy Now | 220.86% | Barclays | Steve Valiquette53% | $15 → $12 | Maintains | Overweight | Get Alert |
| 07/18/2022 | Buy Now | 247.59% | Guggenheim | Sandy Draper73% | $17 → $13 | Maintains | Buy | Get Alert |
| 06/23/2022 | Buy Now | 73.8% | RBC Capital | Sean Dodge46% | $8 → $6.5 | Maintains | Sector Perform | Get Alert |
| 06/22/2022 | Buy Now | 60.43% | Baird | Vikram Kesavabhotla50% | $7 → $6 | Maintains | Neutral | Get Alert |
| 06/13/2022 | Buy Now | 140.64% | Cowen & Co. | Charles Rhyee36% | $22 → $9 | Maintains | Market Perform | Get Alert |
| 06/10/2022 | Buy Now | 140.64% | Goldman Sachs | Eric Sheridan79% | $12 → $9 | Downgrade | Buy → Neutral | Get Alert |
| 06/06/2022 | Buy Now | 194.12% | B of A Securities | Michael Cherny78% | → $11 | Reinstates | → Buy | Get Alert |
| 06/01/2022 | Buy Now | 87.17% | Baird | Vikram Kesavabhotla50% | $10 → $7 | Downgrade | Outperform → Neutral | Get Alert |
FAQ
What is the target price for GoodRx Holdings (GDRX) stock?
The latest price target for GoodRx Holdings (NASDAQ:GDRX) was reported by UBS on May 13, 2025. The analyst firm set a price target for $5.25 expecting GDRX to rise to within 12 months (a possible 40.37% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for GoodRx Holdings (GDRX)?
The latest analyst rating for GoodRx Holdings (NASDAQ:GDRX) was provided by UBS, and GoodRx Holdings maintained their neutral rating.
When was the last upgrade for GoodRx Holdings (GDRX)?
The last upgrade for GoodRx Holdings Inc happened on May 23, 2024 when RBC Capital raised their price target to $10. RBC Capital previously had a sector perform for GoodRx Holdings Inc.
When was the last downgrade for GoodRx Holdings (GDRX)?
The last downgrade for GoodRx Holdings Inc happened on January 2, 2024 when B of A Securities changed their price target from $8 to $4.5 for GoodRx Holdings Inc.
When is the next analyst rating going to be posted or updated for GoodRx Holdings (GDRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GoodRx Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GoodRx Holdings was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
Is the Analyst Rating GoodRx Holdings (GDRX) correct?
While ratings are subjective and will change, the latest GoodRx Holdings (GDRX) rating was a maintained with a price target of $6.00 to $5.25. The current price GoodRx Holdings (GDRX) is trading at is $3.74, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
